T lymphocytes come in two major varieties that can be distinguished by their function and specificity for antigen. The CD4 + (helper) and CD8 + (killer) subsets are specific for peptides presented by class II and class I major histocompatibility complex (MHC) molecules, respectively. Recent data [1] [2] [3] [4] suggest that the generation of these distinct subsets requires different signals generated by the T-cell receptor complex during positive selection. This finding is consistent with, but does not prove, the proposal that developing T lymphocytes are instructed by their receptors to differentiate along distinct developmental pathways.
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Correlation of function and specificity
As a rule, activation of CD4 + T cells to differentiate into effective cytokine-producing cells with poor cytolytic potential requires binding of the T-cell antigen receptor to class II MHC-peptide complexes. Conversely, induction of potent cytolytic activity in CD8 + T cells requires binding of their T-cell receptor to class I MHC-peptide complexes. These facts raised the puzzling question of how the functional capacity of T cells could be correlated with receptor specificity, especially because it was clear that the functional capacity was pre-programmed in resting T cells. Initially it could not be ruled out that the apparent correlation of function and T-cell receptor specificity was simply due to the expression of the invariant CD4 and CD8 coreceptors on these subsets. The two lineages could be argued to express T-cell receptors in a completely random fashion, with activation requiring coligation of CD4 or CD8 coreceptors with the T-cell receptor by the same MHC-peptide complex. This proposal could have served as a perfect explanation for why CD4 + cells and CD8 + cells are activated by class II and class I MHC complexes, respectively, since the invariant CD4 and CD8 molecules bind to the invariant part of class II and class I MHC molecules.
According to this concept, CD4 + cells with class-I-specific T-cell receptors and CD8 + cells with class-II-specific T-cell receptors would not be activated and would represent 'waste' in the pool of long-lived mature T cells.
T-cell receptor transgenes yield new clues
The analysis of mice that transgenically express particular types of T-cell receptor definitively ruled out the above hypothesis. These experiments showed that class-I-specific or class-II-specific transgenic T-cell receptors were expressed exclusively on CD8 + and CD4 + mature T cells, respectively [5, 6] . This finding clearly indicated that the specificity of randomly generated T-cell receptors for self-MHC molecules somehow determined the differentiation of thymocytes into CD4 + or CD8 + T cells, as well as the functional phenotype of the mature T cells. These studies therefore revealed that binding of T-cell receptors on immature CD4 + CD8 + thymocytes to thymic MHC molecules was not only required to rescue these cells from programmed cell death -death from 'neglect' -but also to determine both the functional potential and the CD4 + or CD8 + phenotype of the rescued cells, depending on whether the receptors bound to class I or class II MHC molecules, respectively.
Revised hypotheses
Two distinct hypotheses were formulated in order to account for this process. The initial proposal stated that binding of the T-cell receptor complex, including coreceptor molecules, to class I or class II MHC ligands resulted in different signals instructing immature lymphocytes to differentiate along one or the other developmental pathway [7] . A later hypothesis argued that the lineage choice was initiated by receptor ligation but was stochastic, resulting in downregulation of either CD4 or CD8. It was further postulated that the subsequent rescue from cell death required coligation of coreceptor and T-cell receptor by the same MHC-peptide complex. Thus, cells with mismatched coreceptor-T-cell receptor combinations would die at this stage and only cells with the correct, matched combination would survive [8] . When considering the effects on cell numbers, the second model was more wasteful but required only a single rescue signal irrespective of whether the coreceptor-T-cell receptor complex bound to class I or class II MHC molecules. Variations of these two models were also proposed but shall not be discussed here for the purpose of clarity.
Testing models of lineage choice
Different sets of findings were cited to support either the stochastic or the instructive hypothesis. For instance, the existence of CD4 + CD8 low cells in mice lacking class II MHC expression was thought to be indicative of an initial stochastic lineage decision. The ability to rescue CD4 + cells expressing class-I-specific T-cell receptors and CD8 + cells expressing class-II-specific T-cell receptors with CD8 and CD4 transgenes, respectively, was also thought to support stochastic commitment [8, 9] . These 'abnormal' or mismatched subsets were not observed with all transgenic T-cell receptor models, however, and thus one could argue that these abnormal cells were indicative of 'mistakes' in instruction rather than of stochastic lineage decisions. Also other data were initially interpreted to support evidence for stochastic processes: in particular the effect of a Notch transgene that appeared to introduce a bias in the CD4:CD8 ratio and was able to rescue the differentiation of CD8 + thymocytes in mice lacking in class I MHC expression was considered to support stochastic CD4/CD8 lineage commitment [10] . These studies, however, could not exclude the possibility that this mechanism was dependent on specific signaling by the T-cell receptor complex binding to class I MHC molecules and thus part of an instructive scenario. More recent evidence suggests that Notch can in fact rescue CD4 + as well as CD8 + cells [11] .
Other findings implicating the T-cell-specific protein tyrosine kinase p56 lck were interpreted to support the instructive model. Forms of CD8α were generated that contained a CD4 cytoplasmic tail; these chimeras could pair with CD8β molecules and recruit a considerably larger amount of p56 lck than a wild-type CD8α-CD8β heterodimer. In corresponding transgenic mice, a significant increase in CD4 + CD8 -cells that expressed a class-I-restricted transgenic T-cell receptor as well as the CD8-CD4 chimera was observed [12] . Also CD4-deficient mice exhibited a considerable increase in CD8 + T cells expressing a class-II-specific T-cell receptor [13] . Both sets of data were consistent with the idea that stronger signaling by p56 lck favors the CD4 lineage whereas generation of CD8 cells requires less p56 lck activity. Although these data were clearly consistent with the instructive model, they could not rule out that the initial commitment was stochastic and that different signals were required to rescue already committed cells.
Direct evidence for a role of p56 lck
More recent experiments published in several papers consolidate the above notions: while these studies do not rigorously rule out stochastic commitment, they do tilt the balance in favour of an instructive process. Three independent sets of observations argue that p56 lck has a role in determining CD4/CD8 lineage fate. First, the expression of a catalytically active form of p56 lck in combination with a class-I-specific T-cell receptor resulted in CD4 + cells with class I-restricted receptors; conversely, the expression of a catalytically inactive form of p56 lck with class-II-specific T-cell receptors resulted in CD8 + cells with class-II-restricted receptors [1] . These data directly showed that the presence of more active p56 lck favors the generation of CD4 + T cells. Second, in another yet unpublished study (R. Perlmutter, personal communication), it has been shown that active p56 lck can promote development of mature T cells even in the absence of T-cell receptor-MHC interactions and that higher levels of active p56 lck correlate with a high ratio of CD4 + :CD8 + cells. Third, in mice expressing a hormone-inducible form of p56 lck that had been bred onto a p56 lck-/-background, it was found that induction of p56 lck activity resulted in a more prominent rescue of CD4 + than CD8 + T cells [2] . Thus, all three studies agree that higher p56 lck activity favors the generation of mature CD4 + T cells. These data also correlate well with earlier in vitro studies that used pharmacological reagents to show that stronger activation of CD4 + CD8 + thymocytes results in CD4 + CD8 -cell differentiation [14] .
Lineage commitment in vitro
A set of completely different, but rather intriguing, experiments led to the notion that the duration of signaling by the αβ T-cell receptor complex in immature thymocytes determines the CD4 + versus CD8 + lineage fate [3] . The authors used a two-stage culture system in which CD4 + CD8 + thymocytes were first cultured in the presence of dendritic cells and then, after washing, with dendritic cells as well as thymic stromal cells. Lineage fate was found to be decided in the first 24 hour culture period, whereas the second culture period was only required to execute the program initiated in the first 24 hour period. We should be aware of a key non-physiological component in this assay, however, namely the co-culture of CD4 + CD8 + thymocytes with dendritic cells in the first stage. Under physiological conditions in the thymic cortex, CD4 + CD8 + cells only have access to epithelial cells and few macrophages, and epithelial cells are of crucial importance in positive selection. These in vivo observations, however, do not rule out the possibility that Dispatch R643 Table 1 Lineage fate determination of CD4 + CD8 + thymocytes. other cells might also be capable of initiating positive selection under appropriate conditions [3] .
Genotype of APCs
The salient findings in this system are as follows: CD4 + CD8 + cells with a class-II-restricted receptor that can effectively coengage the T-cell receptor as well as the CD4 coreceptor in the first culture become CD4 + mature T cells in the second culture. CD4 + CD8 + cells expressing the same T-cell receptor but that are incapable of engaging the CD4 coreceptor -because of a mutation in the invariant part of the class II MHC molecule -become CD8 + cells in the second culture. The authors point out that it is irrelevant whether or not the cells encounter the wild-type or mutant MHC molecule in the second culture, thereby demonstrating that strong engagement of CD4 is not required for CD4 + cells developing in the second culture. (Nevertheless, the generation of the CD8 + T cells with the class-II-restricted T-cell receptor requires class I MHC molecules in the second culture, revealing that engagement of CD8 is required in the second culture. This notion is consistent with earlier findings of the generation of CD8 + T cells with a class-II-restricted T-cell receptor under more physiological conditions [15] .) These results led the authors to dispute the idea that a matching combination of CD4 coreceptor and T-cell receptor is generally required to select cells for survival after commitment to the CD4 lineage [3] .
Although these data might be interpreted to support the idea that CD4-associated p56 lck is required for CD4 lineage commitment, the authors go on to argue that this is not essential under any condition. The authors showed that, when providing an agonist ligand in the first culture, in this particular case, a class-I-presented peptide to CD4 + CD8 + cells expressing a class-I-restricted T-cell receptor, and in the second culture providing class I MHC molecules lacking the agonist peptide (because otherwise cell death by deletion would ensue), the CD4 + CD8 + cells assumed the CD4 + instead of the CD8 + phenotype. If CD4 + CD8 + cells were, however, cultured in the absence of the agonist peptide at both stages of culture but in the presence of the appropriate MHC molecules, all cells became CD4 -CD8 + (Table 1) . Thus, the absence or presence of the agonist peptide in the first culture determined whether CD8 + and CD4 + cells, respectively, were obtained. Since under these conditions the CD4 coreceptor cannot be coligated by the class I MHC-agonist peptide complex, we can conclude that strong signaling by the T-cell receptor in the absence of CD4 coengagement can result in the generation of CD4 + lineage cells.
The authors then attempted to define 'strong signaling' and showed that in the first culture the commitment to the CD4 + lineage required a minimum of 14 hours of coculture with the agonist peptide whereas, after 1.5 hours of coculture only, CD8 + cells were obtained in the second culture. Thus, the duration of receptor engagement is of crucial importance with regard to lineage choice. It is possible that CD4 molecules may contribute normally to the duration of T-cell receptor engagement. A final experiment concerned the role of Notch1 in this process: treatment with antisense Notch1 oligonucleotides as well as anti-Notch1 antibody-blocking experiments showed that after lineage commitment the development of the CD8 lineage was more dependent on Notch1 than the development of the CD4 lineage. Notch1 may have an important survival function in the CD8 lineage.
The authors are careful to point out that, although these data are clearly consistent with an instructive scheme of CD4/CD8 lineage commitment, the results do not completely rule out the possibility that stochastic commitment occurs, followed by selection requiring special rescue signals for each lineage in the first culture. If stochastic commitment did indeed occur, it would have to be associated (Note that this model [4] is not entirely compatible with the observation that lineage commitment is fixed before coreceptor downregulation [3] [16] . The caveat with such data is that it is difficult to exclude the loss of a significant fraction of cells during positive selection when using DNA labeling analysis.
The instructive model of CD4/CD8 lineage commitment has been recently revised by experiments suggesting that CD4 + CD8 + cells upon T-cell receptor ligation during positive selection always downregulate the CD8 coreceptor initially [4] . The resulting CD4 + CD8 -cells would then be instructed by coligation of a class-II-restricted T-cell receptor and CD4 coreceptors to develop along the CD4 + CD8 -pathway. The CD4 + CD8 -intermediates with a class-Irestricted T-cell receptor would only receive a weak signal because of the absence of the CD8 coreceptor but would now be instructed by IL-7 to undergo coreceptor reversal and become CD4 -CD8 + cells. CD4 + CD8 -cells with a class-II-restricted T-cell receptor would, because of the strong T-cell receptor signal, become resistant to IL-7-induced coreceptor reversal [4] (Figure 1 ). This intriguing model makes some strong predictions: transgenic CD8α-CD8β heterodimers should result in mature T cells that express endogenous CD4 but not CD8. Also, IL-7 receptor deficient mice should not have CD8 T cells. These predictions are not always completely fulfilled [12] and thus additional assumptions need to be made, also with regard to the findings discussed earlier suggesting that lineage fate decision occurs before coreceptor downregulation [3] .
Presently and for some time we are and have been exposed to a wave of experiments interpreted to favor instructional mechanisms of CD4/CD8 lineage commitment. In reality, we now have good evidence that differences in T-cell receptor signaling intensity (duration) are decisive in CD4 versus CD8 lineage commitment. Thus, while all the ingredients for an instructive mechanism are present, the possibility of a stochastic commitment step has not quite yet been eliminated. Should we say that the remaining questions are only of academic interest because now we have good clues about how to influence the determination of lineage fate? Perhaps with the closing of the Basel Institute for Immunology we have to leave it at that.
